Health / Medical Topics |
JAK Inhibitor INCB047986
An orally bioavailable inhibitor of Janus-associated kinases (JAK), with potential antineoplastic activity. Upon oral administration, INCB047986 specifically binds to and inhibits the phosphorylation of JAK, which affects JAK-dependent signaling and may lead to an inhibition of cellular proliferation in JAK-overexpressing tumor cells. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies. (NCI Thesaurus)
YOU MAY ALSO LIKE
Human JAG2 wild-type allele is located in the vicinity of 14q32 and is approximately 27 kb in length. This allele, which encodes…
This gene plays a role in cell fate determination.
Human JAG1 wild-type allele is located within 20p12.1-p11.23 and is approximately 36 kb in length. This allele, which encodes protein jagged-1, may…
This gene may be involved in hematopoiesis.
A very rare genetic syndrome caused by deletion of the terminal band of chromosome 11. It is characterized by the presence of…
The Jack Russell Terrier Wire is a wire-coated variety of the Jack Russell Terrier.